CompoAtlas

Ashwagandha bio en poudre

Food supplement declared in France, decision dated 24 September 2025

Ashwagandha bio en poudre (Terravita) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Withania somnifera 2 g per day. None of the rules we check flags an issue with its declared composition.

Brand
Terravita
Food business operator placing the product on the market
LABORATOIRE TERRAVITA
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Powder
Daily dose
2 g
Directions for use
prendre une demi-cuillère à café de poudre (environ 2g) à mélanger avec de l’eau, du lait ou un jus de fruits.
Intended populations
General population
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Heart problems, Liver problems, Taking antidepressants
Objectives stated by the manufacturer (these are not authorised claims)
Autre : Vitalité, résistance de l'organisme

Declaration 341146, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalRacinePoudre (de plantes séchées ou broyées)2 g

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

se conformer aux conseils d’utilisation. Les compléments alimentaires doivent être utilisés dans le cadre d’un mode de vie sain et ne pas être utilisés comme substituts d’un régime alimentaire varié et équilibré. Ne pas dépasser la dose journalière recommandée. Tenir hors de la portée des jeunes enfants. Déconseillé chez les femmes enceintes et allaitantes, ainsi que chez les personnes atteintes de troubles endocriniens, hépatiques ou cardiaques. Réservé à l'adulte. Déconseillé chez les personnes suivant un traitement ayant une action dépressive du système nerveux central. À conserver à l’abri de la lumière dans un endroit frais et sec.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera (L.) Dunal
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Sources cited by Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Sources cited by Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Terravita

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ashwagandha bio en poudre (Terravita): composition and regulation”, https://compoatlas.com/en/supplements/products/341146-ashwagandha-bio-en-poudre, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line